| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
11,750,000 |
| Market
Cap: |
7.94(M) |
| Last
Volume: |
121,966 |
Avg
Vol: |
480,151 |
| 52
Week Range: |
$0.67535 - $1.71 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Biomerica is a biomedical technology company that develops, patents, manufactures and markets diagnostic and therapeutic products used at the point-of-care (physicians' offices and over-the-counter through drugstores and online) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. Co.'s diagnostic test kits are used to analyze blood, urine, nasal or fecal material from patients in the diagnosis of various diseases, food intolerances and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in small concentrations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
15,600 |
23,128 |
| Total Buy Value |
$0 |
$0 |
$20,154 |
$41,908 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
9 |
13 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Irani Zacharys |
Chief Executive Officer |
• • – |
2023-05-25 |
4 |
B |
$1.55 |
$310 |
D/D |
200 |
1,020,560 |
2.73 |
-49% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-05-24 |
4 |
B |
$1.61 |
$805 |
D/D |
500 |
1,020,360 |
2.73 |
-49% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-05-12 |
4 |
B |
$1.17 |
$1,989 |
D/D |
1,700 |
1,019,860 |
2.73 |
-6% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-05-10 |
4 |
B |
$1.27 |
$635 |
D/D |
500 |
1,018,160 |
2.73 |
-11% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-05-09 |
4 |
B |
$1.39 |
$417 |
D/D |
300 |
1,017,660 |
2.73 |
-15% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-05-04 |
4 |
B |
$1.36 |
$1,360 |
D/D |
1,000 |
1,017,360 |
2.73 |
-21% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-04-28 |
4 |
B |
$1.34 |
$2,412 |
D/D |
1,800 |
1,017,360 |
2.73 |
-9% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-04-27 |
4 |
B |
$1.31 |
$3,406 |
D/D |
2,600 |
1,017,360 |
2.73 |
-3% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-04-26 |
4 |
B |
$1.26 |
$8,820 |
D/D |
7,000 |
1,012,960 |
2.81 |
2% |
|
| Barbieri Allen |
Executive Vice Chairman |
• • – |
2023-01-27 |
4 |
B |
$2.94 |
$4,522 |
D/D |
1,538 |
101,327 |
2.73 |
-52% |
|
| Coste Catherine |
Audit Committee Chairperson |
– • – |
2023-01-26 |
4 |
B |
$2.96 |
$6,482 |
D/D |
2,190 |
43,790 |
2.39 |
-57% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-01-25 |
4 |
B |
$2.85 |
$5,130 |
D/D |
1,800 |
1,005,960 |
2.81 |
-56% |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2023-01-24 |
4 |
B |
$2.81 |
$5,620 |
D/D |
2,000 |
1,004,160 |
2.81 |
-55% |
|
| Coste Catherine |
Director |
– • – |
2020-10-26 |
4 |
B |
$5.45 |
$49,595 |
I/I |
9,100 |
9,100 |
2.1 |
1% |
|
| Cano Francis |
Director |
– • – |
2020-10-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
146,736 |
|
- |
|
| Sirgo Mark A |
Director |
– • – |
2020-04-21 |
4 |
S |
$8.11 |
$40,532 |
D/D |
(5,000) |
8,700 |
|
10% |
|
| Sirgo Mark A |
Director |
– • – |
2020-04-17 |
4 |
S |
$8.05 |
$40,346 |
D/D |
(5,000) |
13,700 |
|
9% |
|
| Barbieri Allen |
Director |
– • – |
2020-04-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,000 |
137,289 |
|
- |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2020-02-28 |
4 |
A |
$2.85 |
$223,528 |
D/D |
78,431 |
1,002,160 |
|
- |
|
| Moore Janet |
Chief Financial Officer |
• • – |
2020-01-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
101,720 |
|
- |
|
| Moore Janet |
Chief Financial Officer |
• • – |
2019-10-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
121,720 |
|
- |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2018-12-21 |
4 |
A |
$1.82 |
$6,914 |
D/D |
3,600 |
923,729 |
|
- |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2018-12-20 |
4 |
A |
$2.45 |
$980 |
D/D |
400 |
920,129 |
|
- |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2018-12-19 |
4 |
A |
$2.45 |
$1,968 |
D/D |
800 |
919,729 |
|
- |
|
| Irani Zacharys |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
A |
$2.70 |
$90,153 |
D/D |
33,390 |
918,929 |
|
- |
|
135 Records found
|
|
Page 1 of 6 |
|
|
0.04 (5.28%) 
